AdultStemCell.com

First patient to get stem cell therapy identified
The partially paralyzed young man who was the first person treated in the only carefully designed study of a therapy made from human embryonic stem cells is in good spirits and hopeful about recovering, family and friends said in the first public acknowledgment of his identity and condition.
Read more on Pittsburgh Post-Gazette

Human embryonic stem cells provide new insight into muscular dystrophy
Myotonic dystrophy type 1 is the most common inherited muscular dystrophy in adults. New research uses human embryonic stem cells to make a clinically important contribution to the understanding of this disease, and highlights the incredible potential that embryonic stem cells hold for unraveling the complex molecular mechanisms involved in a variety of human conditions.
Read more on Science Daily

Human Embryonic Stem Cells Provide New Insight Into Muscular Dystrophy
Myotonic dystrophy type 1 (DM1) is the most common inherited muscular dystrophy in adults. New research published by Cell Press online on March 31st in the journal Cell Stem Cell, uses human embryonic stem cells to make a clinically-important contribution to the understanding of this disease, and highlights the incredible potential that embryonic stem cells hold for unraveling the complex …
Read more on redOrbit

The Human Embryonic Stem Cell Debate: Science, Ethics, and Public Policy (Basic Bioethics)

Human embryonic stem cells can divide indefinitely and have the potential to develop into many types of tissue. Research on these cells is essential to one of the most intriguing medical frontiers, regenerative medicine. It also raises a host of difficult ethical issues and has sparked great public interest and controversy. This book offers a foundation for thinking about the many issues involved in human embryonic stem cell research. It considers questions about the nature of human life, t

Rating: (out of reviews)

List Price: $ 27.00

Price: $ 4.39

EU Partners Advance Multicore and Networking Tech
The EUREKA ITEA 2 software Cluster ParMA project , a software development effort supported by a technology development initiative comprised of European Union members, has announced the completion of several technology development projects that aim to exploit multicore processor architectures to deliver substantial performance improvements for high-performance computing.
Read more on GenomeWeb News

Please Participate in Our Annual Survey of Next-Gen Sequencing Users
‘Tis the season to be surveyed! Please take a moment to respond to a few questions for In Sequence ‘s fourth annual survey of users of next-generation sequencing platforms.
Read more on GenomeWeb News

by dumplife (Mihai Romanciuc)

Future Growth Projection For Human Embryonic Stem Cells (Hescs) Market

Opportunities in Human Embryonic Stem Cells hESCs Report ( http://www.bharatbook.com/Market-Research-Reports/Opportunities-in-Human-Embryonic-Stem-Cells-hESCs.html ) gives the information about types of stem cell.
 
 Human embryonic stem cells (hESCs) are stem cells derived from the inner cell mass of a blastocyst, which is a stage reach 4-5 days post fertilization. hESCs are the most pluripotent of all stem cell types and can develop into over 200 different cell types of the human body.
 
 hESCs were first derived from mouse embryos in 1981 by Martin Evans and Matthew Kaufman, and independently by Gail R. Martin. In 1995, the first successful culturing of embryonic stem cells from non-human primates occurred at the University of Wisconsin-Madison. Another breakthrough followed at the University of Wisconsin-Madison in November 1998 when a group led by Dr. James Thomson developed a technique to isolate and grow hESCs derived from human blastocysts. Federal funds to support hESC research became available on August 9, 2001, when President Bush announced his decision regarding federal funding for hESC research.
 
 Because of their plasticity and unlimited capacity for self-renewal, hESCs have been proposed for use in wide range of applications, including toxicology testing, tissue engineering, cellular therapies, and basic stem cell biology research. Of particular interest to the medical community is the potential for use of hESCs to heal tissues with naturally limited capacity for renewal, such as the human heart, liver and brain.
 
 This market report recognizes that a wide range of products and services are needed to support this active and well-funded research community. Thus, this report provides:
 
 * Discussion of key advances in hESC research
 * A breakdown of hESC research applications, including shared priorities and priorities by segment
 * hESC patent analysis
 * Historical and future growth projections for the hESC market
 * Competitive analysis of providers of hESC research tools
 * Overview of specialty pharma companies developing hESC therapies
 * Overview of toxicology testing legislation impacting use of hESC in toxicology applications
 * A breakdown of hESC research product categories
 * Suggestions for novel NSC research products, including cells, kits, assays, media and reagents
 * Guidance for companies that wish to offer hESCs products
 * And more… 

 
 Contact us at:
 
 Bharat Book Bureau
 Tel: 91 22 27578668
 Fax: 91 22 27579131
 Email: info@bharatbook.com
 Website: www.bharatbook.com